Delivery Order SPE2DR25D1053-SPE2DR26FV973
- Not listed
- The Defense Logistics Agency awarded a $15,493.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 28, 2026, for the supply of Zepbound 5 mg/0.5 ml pens. The order is scheduled for completion by January 29, 2026, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a task order under AmerisourceBergen's larger relationship with the...
- The Defense Logistics Agency awarded a $30,754.05 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 27, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pens, with a completion date of January 28, 2026. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates...
- The Defense Logistics Agency awarded a delivery order valued at $4,710.68 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 7, 2026, for the supply of Zepbound 10 mg/0.5 mL pens. This competitive, firm fixed-price delivery order is scheduled for ultimate completion on January 8, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $28,435.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 21, 2026, for the supply of Zepbound 15 mg/0.5 ml pens. The order, with an ultimate completion date of January 22, 2026, will be performed at the awardee's location in Conshohocken, Pennsylvania. This delivery order was awarded competitively with no set-aside designation and represents a single task order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,094.84 delivery order to AmerisourceBergen Drug Corp (a subsidiary of parent company Cencora, Inc.) on January 23, 2026, for the supply of Zepbound 15 mg/0.5 mL pens. This firm fixed-price delivery order is scheduled for completion by January 26, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis and represents a task order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,570.92 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order valued at $14,024.40 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania and an ultimate completion date of January 13, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $38,343.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 29, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pens. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of January 30, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $31,315.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 14, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This non-set-aside award was completed on January 15, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $67,932.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 30, 2026, for the supply of Zepbound 12.5 mg/0.5 mL pen injections with completion scheduled for February 2, 2026. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV973Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,747.36 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on February 2, 2026, for the supply of Zepbound 10 mg/0.5 mL pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 3, 2026, and will be performed at the vendor's location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical vendor that supplies brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains to military treatment facilities and other federal healthcare systems. As a subsidiary of Cencora, Inc., the company competes on a full and open basis for federal contracts and has demonstrated extensive capability in fulfilling delivery orders for diverse pharmaceutical products. This delivery order for Zepbound, a diabetes medication, reflects the company's role in providing essential prescription medications to support Department of Defense healthcare operations and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.7k | 2/1/26 |